BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

6 Months Ended

Jun. 30, 2017

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three and six months ended June 30, 2017 and 2016 are as follows:

	Three Months Ended								Six Months Ended
	June 30,								June 30,
	2017				2016				2017				2016
Laser systems		63.1	%			70.7	%			62.6	%			67.0	%
Imaging systems		7.5	%			5.0	%			6.7	%			5.6	%
Consumables and other		16.3	%			12.5	%			15.9	%			14.1	%
Services		12.8	%			11.4	%			14.5	%			13.0	%
License fees and royalties		0.3	%			0.4	%			0.3	%			0.3	%
Total revenue		100.0	%			100.0	%			100.0	%			100.0	%